Global Phage Therapy Market is expected to grow at an 20.50% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Phage therapy industry is experiencing huge research and development activities to develop products for different diseases and applications.The global phage therapy market is under development with no FDA-approved products. In the current scenario, natural phage-based products and compassionate phage therapy (CPT) are available in the market, which comprises current market revenue. Players such as Microgen (Russia), Duopharm (Germany), SES DERMA (Peru), BIOMED PERM NPO (Russia), and Phage Therapy Center are offering treatment for patients with chronic infectious diseases. However, the global phage therapy market has a tremendous opportunity to grow during the forecast period. By region, Europe dominates the market with a share of 57.0% of the global phage therapy market. Russia and Germany are the key markets holding the majority of the market for phage therapy in the region.
The market has reputed players across the globe with massive investment in clinical trials/ R&D activities. Clinical trial/product development companies in the market form strategic alliances with key pharmaceutical vendors to seek investment and tap potential markets in upcoming forecast years. Strategic alliances with contract manufacturers, the scientific community, and policymakers will enhance the development of phage therapy for clinical trials companies. The rapid increase in investment in the phage industry has been seen in recent years due to significant market opportunities in upcoming years.
· Adaptive Phage Therapeutics
· Armata Pharmaceuticals
· BiomX (MBcure Ltd.)
· Locus Biosciences
· Intralytix, Inc.
· Pherecydes Pharma
· PhagoMed Biopharma
· PHAXIAM Therapeutics
· Technophage (TechnoPhage S.A.)
· Phage International
· Eliava BioPreparations
· Phagelux
· Nextbiotics
· Micreos Human Health
· ContraFect
· EnBiotix
· Proteon Pharmaceuticals
· PhagePro, PBC
· SNIPR Biome
· Eligo Bioscience
The global phage therapy market is segmented on the basis of Distribution Channel, Route of Administration, Targeted Bacteria, Disease Indication and region. As per the Distribution Channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. By Route of Administration, the market is divided into Oral, Topical, Rectal Route, and Intravenous Route. According to the Targeted Bacteria, the market is segmented into Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, and Other Bacteria. The Disease Indication segment comprises Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, and Other Disease Indications. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 20.5% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025 to 2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Distribution Channel, By Route of Administration, By Target Pathogen, By Target Indication, By development stage, By Product Type, |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia; |
| Competitive Landscape | Armata Pharmaceuticals, Inc., BiomX (MBcure Ltd.), Eligo Bioscience, Intralytix, Inc., iNtODEWorld, Locus Biosciences, MicroPhage, Inc., TechnoPhage, Microgen Russia, Aumed, Aziya immunopreparat LLC, Sensei Biotherapeutics, Eliava BioPreparations, Nextbiotics, PhagePro, Nexabiome, Other Prominent Players |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Phage Therapy Market Snapshot
Chapter 4. Global Phage Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Route of Administration, Estimates & Trend Analysis
5.1. By Route of Administration, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Route of Administration:
5.2.1. Oral
5.2.2. Topical
5.2.3. Rectal Route
5.2.4. Intravenous Route
5.2.5. Inhalation
Chapter 6. Market Segmentation 1: By Product Type, Estimates & Trend Analysis
6.1. By Product Type, & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
6.2.1. Monophage
6.2.2. Phage Cocktails
6.2.3. Combination Products
6.2.4. Phage-Derived Enzymes
Chapter 7. Market Segmentation 1: By Development Stage, Estimates & Trend Analysis
7.1. By Development Stage, & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Development Stage:
7.2.1. Preclinical Topical
7.2.2. Phase I / II Intravenous Route
7.2.3. Compassionate
7.2.4. Phase III
Chapter 8. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
8.1. By Distribution Channel & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Market Segmentation 3: By Target Pathogen Estimates & Trend Analysis
9.1. By Target Pathogen & Market Share, 2024 & 2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Target Pathogen:
9.2.1. Gram-Negative Bacteria
9.2.2. Gram-Positive Bacteria
9.2.3. Mixed / Other Pathogens
Chapter 10. Market Segmentation 3: By Target Indication Estimates & Trend Analysis
10.1. By Target Indication & Market Share, 2024 & 2034
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Target Indication:
10.2.1. Urinary Tract Infections
10.2.2. Chronic Otitis
10.2.3. Dental Extraction
10.2.4. Chronic Ulcerative Colitis
10.2.5. Bone Infection
10.2.6. Wound and Skin Infections
10.2.7. Cystic Fibrosis
10.2.8. Other Disease Indications
Chapter 11. Phage Therapy Market Segmentation 5: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2021-2034
11.1.2. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
11.1.3. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
11.1.4. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.1.5. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by Development Stage, 2021-2034
11.1.6. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by Product Type, 2021-2034
11.2. Europe
11.2.1. Europe Phage Therapy Market revenue (US$ Million) By Route of Administration, 2021-2034
11.2.2. Europe Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2021-2034
11.2.3. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
11.2.4. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.2.5. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts by Development Stage, 2021-2034
11.2.6. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts by Product Type, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Phage Therapy Market revenue (US$ Million) By Route of Administration, 2021-2034
11.3.2. Asia Pacific Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2021-2034
11.3.3. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
11.3.4. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.3.5. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts by Development Stage, 2021-2034
11.3.6. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts by Product Type, 2021-2034
11.4. Latin America
11.4.1. Latin America Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2021-2034
11.4.2. Latin America Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
11.4.3. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
11.4.4. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.4.5. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts by Development Stage, 2021-2034
11.4.6. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts by Product Type, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2021-2034
11.5.2. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
11.5.3. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
11.5.4. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
11.5.5. Middle East & Africa Therapy Market revenue (US$ Million) estimates and forecasts by Development Stage, 2021-2034
11.5.6. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts by Product Type, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Adaptive Phage Therapeutics
12.2.2. Armata Pharmaceuticals
12.2.3. BiomX (MBcure Ltd.)
12.2.4. Locus Biosciences
12.2.5. Intralytix, Inc.
12.2.6. Pherecydes Pharma
12.2.7. PhagoMed Biopharma
12.2.8. PHAXIAM Therapeutics
12.2.9. Technophage (TechnoPhage S.A.)
12.2.10. Phage International
12.2.11. Eliava BioPreparations
12.2.12. Phagelux
12.2.13. Nextbiotics
12.2.14. Micreos Human Health
12.2.15. ContraFect
12.2.16. EnBiotix
12.2.17. Proteon Pharmaceuticals
12.2.18. PhagePro, PBC
12.2.19. SNIPR Biome
12.2.20. Eligo Bioscience
12.2.21. Other Prominent Players
Global Phage Therapy Market by Development Stage
· Preclinical
· Phase I / II
· Phase III
· Compassionate / Expanded Access Use
· Approved / Commercial (Future launches post-2027)
Global Phage Therapy Market Based on Route of Administration
· Topical / Dermal
· Oral
· Injectable / Intravenous
· Inhalation / Nebulized
· Local Instillation (e.g., bladder, sinus, wound cavity)
Global Phage Therapy Market Based on By Product Type / Mechanism
· Monophage
· Phage Cocktails
· Engineered / Recombinant Phages
· Phage-Derived Enzymes
· Combination Products
Global Phage Therapy Market Based on By Target Indication
· Skin & Wound Infections
· Respiratory Tract Infections
· Urinary Tract Infections (UTI)
· Bone & Joint / Implant-Associated Infections
· Bloodstream / Sepsis
· Gastrointestinal Infections
· Biofilm-related Chronic Infections
Global Phage Therapy Market Based on By Target Pathogen
· Gram-Negative Bacteria
· Gram-Positive Bacteria
· Mixed / Other Pathogens
Global Phage Therapy Market Based on Region
Europe Revenue (US$ Mn) Forecast
North America
Asia Pacific
Latin America
Middle East & Africa